As of 2024-12-13, the Relative Valuation of Redwood Pharma AB (REDW.ST) is - SEK. This relative valuation is based on P/E multiples. With the latest stock price at 1.18 SEK, the upside of Redwood Pharma AB based on Relative Valuation is -.
The range of the Relative Valuation is - SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | - | - |
Forward P/E multiples | - | - |
Fair Price | - | - |
Upside | - | - |
Date | P/E |